Microbiome and Endometrial Receptivity in Obese Infertile Women

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

80 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-05-31

Study Completion Date

2022-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this project is the identification and quantification of the main bacterial communities present in the endometrial microbiota in obese infertile patients, to assess if there is an alteration of their composition dependent on the body mass index, and if such alteration it could influence the reduction of endometrial receptivity, demonstrated in obese women. If obese patients have an altered digestive microbiota and, at the same time, a lower endometrial receptivity, the investigator want to assess whether such reduction in receptivity may depend on an alteration in the endometrial microbiota, which in non-obese infertile patients has been shown to negatively influence the reproductive results

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

New Strategies to Evaluate the Reproductive Tract Microbiome

NCT06920797

Fertility Infertility Reproductive Health +1 more

RECRUITING

Development of a Microbiome Non-invasive Diagnosis Tool

NCT03330444

Infertility of Uterine Origin

COMPLETED

Genomic Endometrial Expression in Obesity

NCT00505986

Obesity and Embryo Implantation

COMPLETED NA

The Temporo-spatial Dynamics of Genital Tract Microbiota - an Observational Study in Oocyte Donors

NCT04393857

Bacterial Vaginoses

COMPLETED

Endometriosis Impact on Oocyte Quality

NCT03241329

Endometriosis

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The main objective of our study is to compare the composition of the endometrial microbiota between patients with normal weight and patients with obesity.

A. Secondary Objectives/research questions

* To analyze the composition of the digestive microbiota through samples of saliva and feces in infertile patients with normal weight and obesity.
* To assess whether there is a relationship between the body mass index (normal weight, obesity Class I, Class II, Class III) and the main bacterial species detected in endometrial fluid samples from infertile patients.
* To evaluate the influence of the digestive microbiota on the composition of the endometrial microbiota according to the body mass index in infertile patients.
* To evaluate if there is an influence of the endometrial microbiota on the results of endometrial receptivity analyzed with the non-invasive Endometrial Receptivity Array test (niERA)

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Endometrial Receptivity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Normal Weight

BMI: Between 18.50 and 29.99 kg/m2

No interventions assigned to this group

Obesity Clas I

BMI between 30 and 34.99 Kg/m2

No interventions assigned to this group

Obesity Clas II

BMI between 35 and 39.99 Kg/m2

No interventions assigned to this group

Obesity Clas III

BMI\> 40 Kg/m2

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Infertile patients undergoing artificial cycle with HRT.
* Normal uterus confirmed by ultrasound (absence of uterine pathology such as submucosal or intramural myomas\> 4 cm that deform cavity, endometrial polyps or Müllerian anomalies, or adnexal as communicating hydrosalpinx).
* Negative serological tests for HIV, HBV, HCV, RPR

Exclusion Criteria

* Taking prescribed antibiotics or using IUDs or contraceptives 3 months prior to taking the sample. NOTE: Patients who have taken prophylactic antibiotics for ovarian puncture may be included at least 1 month before taking the sample.
* Age\> 45 years
* Uncorrected uterine pathology, uncorrected hydrosalpinx
* Recurrent miscarriage (≥2 spontaneous abortions) or failure of implantation (transfer of 6 embryos in day 3 or 4 blastocysts in a cycle of IVF or donation of oocytes without gestation)
* Existence of serious or uncontrolled bacterial, fungal or viral infections that, in the opinion of the principal investigator, could interfere with the participation of the patient in the study or in the evaluation of the results of the study.
* Any disease or medical condition that is unstable or could endanger the patient's safety and compliance in the study.

Minimum Eligible Age

18 Years

Maximum Eligible Age

44 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No